Nihanthy Sreenath, Consultant of Medical Oncology and Hemato-Oncology at Saroj Gupta Cancer Centre and Research Institute, shared a post on LinkedIn:
“Delighted to share that our letter to the editor, ‘KEYNOTE-689 and the Perioperative Paradigm: A Critical Appraisal of Design-Driven Success,’ has been published.
In this piece, we reflect on the trial’s design and its implications for the evolving perioperative immunotherapy landscape in head and neck cancer, focusing on how methodological rigor shapes clinical impact.
Grateful to IJMPO for the opportunity and to my co-author, Dr Akhil Santhosh, for the thoughtful collaboration.”
Title: KEYNOTE-689 and the Perioperative Paradigm:
A Critical Appraisal of Design-Driven Success
Authors: Nihanthy Sreenath and Akhil Santhosh
Other articles featuring Nihanthy Sreenath.